Literature DB >> 17191136

Expression of a myelin proteolipid protein (Plp)-lacZ transgene is reduced in both the CNS and PNS of Plp(jp) mice.

Patricia A Wight1, Cynthia S Duchala, H Elizabeth Shick, Tatyana I Gudz, Wendy B Macklin.   

Abstract

Jimpy (Plp(jp)) is an X-linked recessive mutation in mice that causes CNS dysmyelination and early death in affected males. It results from a point mutation in the acceptor splice site of myelin proteolipid protein (Plp) exon 5, producing transcripts that are missing exon 5, with a concomitant shift in the downstream reading frame. Expression of the mutant PLP product in Plp(jp) males leads to hypomyelination and oligodendrocyte death. Expression of our Plp-lacZ fusion gene, PLP(+)Z, in transgenic mice is an excellent readout for endogenous Plp transcriptional activity. The current studies assess expression of the PLP(+)Z transgene in the Plp(jp) background. These studies demonstrate that expression of the transgene is decreased in both the central and peripheral nervous systems of affected Plp(jp) males. Thus, expression of mutated PLP protein downregulates Plp gene activity both in oligodendrocytes, which eventually die, and in Schwann cells, which are apparently unaffected in Plp(jp) mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17191136      PMCID: PMC1976413          DOI: 10.1007/s11064-006-9202-z

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  46 in total

1.  Characterization of an intronic enhancer that regulates myelin proteolipid protein (Plp) gene expression in oligodendrocytes.

Authors:  Fanxue Meng; Olga Zolova; Natalia A Kokorina; Anna Dobretsova; Patricia A Wight
Journal:  J Neurosci Res       Date:  2005-11-01       Impact factor: 4.164

2.  Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase.

Authors:  Simon N Fewou; Heinrich Büssow; Nicole Schaeren-Wiemers; Marie T Vanier; Wendy B Macklin; Volkmar Gieselmann; Matthias Eckhardt
Journal:  J Neurochem       Date:  2005-07       Impact factor: 5.372

Review 3.  Proteolipid protein gene: Pelizaeus-Merzbacher disease in humans and neurodegeneration in mice.

Authors:  K Woodward; S Malcolm
Journal:  Trends Genet       Date:  1999-04       Impact factor: 11.639

4.  Modification of Schwann cell phenotype with Plp transgenes: evidence that the PLP and DM20 isoproteins are targeted to different cellular domains.

Authors:  T J Anderson; P Montague; N Nadon; K A Nave; I R Griffiths
Journal:  J Neurosci Res       Date:  1997-10-01       Impact factor: 4.164

5.  Expression of a dominant negative IFN-gammareceptor on mouse oligodendrocytes.

Authors:  John M González; Cornelia C Bergmann; Babette Fuss; David R Hinton; Cindy Kangas; Wendy B Macklin; Stephen A Stohlman
Journal:  Glia       Date:  2005-07       Impact factor: 7.452

6.  Protein kinase C activity modulates myelin gene expression in enriched oligodendrocytes.

Authors:  K Asotra; W B Macklin
Journal:  J Neurosci Res       Date:  1993-04-01       Impact factor: 4.164

7.  Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions.

Authors:  L Bö; S Mörk; P A Kong; H Nyland; C A Pardo; B D Trapp
Journal:  J Neuroimmunol       Date:  1994-05       Impact factor: 3.478

8.  MUTANT MICE (QUAKING AND JIMPY) WITH DEFICIENT MYELINATION IN THE CENTRAL NERVOUS SYSTEM.

Authors:  R L SIDMAN; M M DICKIE; S H APPEL
Journal:  Science       Date:  1964-04-17       Impact factor: 47.728

9.  A point mutation in the proteolipid protein gene of the 'shaking pup' interrupts oligodendrocyte development.

Authors:  N L Nadon; I D Duncan; L D Hudson
Journal:  Development       Date:  1990-10       Impact factor: 6.868

10.  Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease.

Authors:  A Gow; C M Southwood; R A Lazzarini
Journal:  J Cell Biol       Date:  1998-02-23       Impact factor: 10.539

View more
  6 in total

1.  The expression of TAG-1 in glial cells is sufficient for the formation of the juxtaparanodal complex and the phenotypic rescue of tag-1 homozygous mutants in the CNS.

Authors:  Maria Savvaki; Kostas Theodorakis; Lida Zoupi; Antonis Stamatakis; Simona Tivodar; Kyriacos Kyriacou; Fotini Stylianopoulou; Domna Karagogeos
Journal:  J Neurosci       Date:  2010-10-20       Impact factor: 6.167

2.  Myelin repair and functional recovery mediated by neural cell transplantation in a mouse model of multiple sclerosis.

Authors:  Lianhua Bai; Jordan Hecker; Amber Kerstetter; Robert H Miller
Journal:  Neurosci Bull       Date:  2013-03-08       Impact factor: 5.203

3.  Constitutively active Akt induces enhanced myelination in the CNS.

Authors:  Ana I Flores; S Priyadarshini Narayanan; Emily N Morse; H Elizabeth Shick; Xinghua Yin; Grahame Kidd; Robin L Avila; Daniel A Kirschner; Wendy B Macklin
Journal:  J Neurosci       Date:  2008-07-09       Impact factor: 6.167

4.  Proteomic analysis of nuclear factors binding to an intronic enhancer in the myelin proteolipid protein gene.

Authors:  Anna Dobretsova; Jennifer W Johnson; Richard C Jones; Ricky D Edmondson; Patricia A Wight
Journal:  J Neurochem       Date:  2008-02-07       Impact factor: 5.372

5.  Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis.

Authors:  Lianhua Bai; Donald P Lennon; Valerie Eaton; Kari Maier; Arnold I Caplan; Stephen D Miller; Robert H Miller
Journal:  Glia       Date:  2009-08-15       Impact factor: 7.452

6.  Identification of direct regulatory targets of the transcription factor Sox10 based on function and conservation.

Authors:  Kyung Eun Lee; Seungyoon Nam; Eun-ah Cho; Ikjoo Seong; Jin-Kyung Limb; Sanghyuk Lee; Jaesang Kim
Journal:  BMC Genomics       Date:  2008-09-11       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.